This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
Kerry Hotel Pudong
September 10–11, 2024 | Shanghai, ChinaSeptember 16–17, 2024 | Virtual

David Wang
Partner at Trinity Innovation Fund
Speaker

Profile

Dr. Wang is currently Partner of Trinity Innovation Fund since 2019. He possesses over 20 years of biomedical research and development (R&D), R&D operation and business development experience. Dr. Wang started his career with start-up biotechs doing small molecule drug discovery and vaccine development in Singapore. In 2007, he moved to China and joined Novartis (China) Institutes for Biomedical Research to oversee scientific operations, R&D alliance and outsourcing with increasing responsibilities. In 2014, he became Asia Pacific Director of Alliance Management in Sanofi, responsible for business development, transaction and alliance management of external R&D and commercial collaborations.

Dr. Wang pursued his Ph.D. degree in Molecular and Developmental Biology and Master degree of Business Administration (MBA) at National University of Singapore. Prior to that, he obtained Bachelor’s degree in Biology and Master’s degree in Biochemistry from Nankai University.

Agenda Sessions

  • Key trends in cross border investment: from local discovery to global innovation

    11:00